IS Pharma goes for growth
By Real Deals, published 2 years ago in Finance & Banking.
Comments
Add a commentRelated Content
- Brad Burton's top tips to win new business
- New bank promises to eliminate "every stupid bank rule"
- Charlie Mullins: New government, new confidence, new jobs
More from this section
Bank of Scotland Corporate is to provide AIM-listed IS Pharma with a facility worth £8m (€10m) to fund the company’s continued growth and acquisition plans.
IS Pharma is a late-stage pharmaceuticals and medical devices business in the specialist hospital medicine sector, with a current focus on critical care, neurology and oncology.
The Chester-based company recently acquired Swiss pharmaceuticals group, Speciality European Pharmaceuticals, for £9.25m.
IS Pharma, previously Maelor, adopted its new name following the acquisition, which has given it a new portfolio of specialist hospital pharmaceutical products.
0 comments.
There are currently no comments. Be the first...